153 related articles for article (PubMed ID: 19058904)
1. Pregnancy under high-dose buprenorphine.
Simmat-Durand L; Lejeune C; Gourarier L;
Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):119-23. PubMed ID: 19058904
[TBL] [Abstract][Full Text] [Related]
2. [Withdrawal syndromes of newborns of pregnant drug abusers maintained under methadone or high-dose buprenorphine: 246 cases].
Lejeune C; Aubisson S; Simmat-Durand L; Cneude F; Piquet M; Gourarier L;
Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():21-7. PubMed ID: 11965095
[TBL] [Abstract][Full Text] [Related]
3. A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome.
Kahila H; Saisto T; Kivitie-Kallio S; Haukkamaa M; Halmesmäki E
Acta Obstet Gynecol Scand; 2007; 86(2):185-90. PubMed ID: 17364281
[TBL] [Abstract][Full Text] [Related]
4. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
Fhima A; Henrion R; Lowenstein W; Charpak Y
Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
[TBL] [Abstract][Full Text] [Related]
5. Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution.
Lejeune C; Simmat-Durand L; Gourarier L; Aubisson S;
Drug Alcohol Depend; 2006 May; 82(3):250-7. PubMed ID: 16257138
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
[TBL] [Abstract][Full Text] [Related]
7. [Opiate addiction in gravidity - consequences for the newborn. Results of an interdisciplinary treatment concept].
Rohrmeister K; Bernert G; Langer M; Fischer G; Weninger M; Pollak A
Z Geburtshilfe Neonatol; 2001; 205(6):224-30. PubMed ID: 11745008
[TBL] [Abstract][Full Text] [Related]
8. [Buprenorphine in pregnancy].
Eder H; Rupp I; Peternell A; Fischer G
Psychiatr Prax; 2001 Sep; 28(6):267-9. PubMed ID: 11533891
[TBL] [Abstract][Full Text] [Related]
9. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
Duburcq A; Charpak Y; Blin P; Madec L
Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
[TBL] [Abstract][Full Text] [Related]
10. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome.
Burns L; Mattick RP
Drug Alcohol Rev; 2007 Sep; 26(5):487-92. PubMed ID: 17701511
[TBL] [Abstract][Full Text] [Related]
11. Management of neonatal abstinence syndrome in neonates born to opioid maintained women.
Ebner N; Rohrmeister K; Winklbaur B; Baewert A; Jagsch R; Peternell A; Thau K; Fischer G
Drug Alcohol Depend; 2007 Mar; 87(2-3):131-8. PubMed ID: 17000060
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine withdrawal syndrome in a newborn.
Marquet P; Chevrel J; Lavignasse P; Merle L; Lachâtre G
Clin Pharmacol Ther; 1997 Nov; 62(5):569-71. PubMed ID: 9390114
[TBL] [Abstract][Full Text] [Related]
13. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study.
Fischer G; Ortner R; Rohrmeister K; Jagsch R; Baewert A; Langer M; Aschauer H
Addiction; 2006 Feb; 101(2):275-81. PubMed ID: 16445556
[TBL] [Abstract][Full Text] [Related]
14. Brain magnetic resonance imaging of infants exposed prenatally to buprenorphine.
Kahila H; Kivitie-Kallio S; Halmesmäki E; Valanne L; Autti T
Acta Radiol; 2007 Mar; 48(2):228-31. PubMed ID: 17354146
[TBL] [Abstract][Full Text] [Related]
15. Perinatal effects of amphetamine and heroin use during pregnancy on the mother and infant.
Thaithumyanon P; Limpongsanurak S; Praisuwanna P; Punnahitanon S
J Med Assoc Thai; 2005 Nov; 88(11):1506-13. PubMed ID: 16471094
[TBL] [Abstract][Full Text] [Related]
16. Neonatal drug addiction.
Fabris C; Prandi G; Perathoner C; Soldi A
Panminerva Med; 1998 Sep; 40(3):239-43. PubMed ID: 9785924
[TBL] [Abstract][Full Text] [Related]
17. Hospital morphine preparation for abstinence syndrome in newborns exposed to buprenorphine or methadone.
Colombini N; Elias R; Busuttil M; Dubuc M; Einaudi MA; Bues-Charbit M
Pharm World Sci; 2008 Jun; 30(3):227-34. PubMed ID: 18008179
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine replacement therapy: a confirmed benefit.
Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
[TBL] [Abstract][Full Text] [Related]
19. [Neonatal abstinence syndrome and maternal toxicological profile].
Fundarò C; Solinas A; Martino AM; Genovese O; Noia G; Conte GL; Segni G
Minerva Pediatr; 1994 Mar; 46(3):83-8. PubMed ID: 8035762
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone.
Jones HE; Johnson RE; Jasinski DR; Milio L
Drug Alcohol Depend; 2005 Apr; 78(1):33-8. PubMed ID: 15769555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
